Bioavailability of two selegiline hydrochloride tablet products.
1996
The bioavailability of two selegiline HCl (CAS 14611-52-0) tablet products was compared in a single-blind, single-dose, randomised, two-way, cross-over study with 25 healthy volunteers. A test preparation of selegiline HCl (4 x 5 mg tablets) was compared to a reference preparation of selegiline HCI (4 x 5 mg tablets). The volunteers were randomised receiving each treatment once. Two clinic days were separated by a wash-out period of between 6 and 14 days. The variable AUC(0-∞) was the primary characteristic of the extent of formation (bioavailability) of the selegiline metabolites, desmethylselegiline and methamphetamine. For desmethylselegiline the point estimate (90 % confidence interval) of the test/reference mean ratio for the variable C max is 98.4% (91.2% to 106%), for AUC(0-∞) 103% (97.6% to 109%). and for C max /AUC(0-∞) 95.6% (89.4% to 102%). For methamphetamine the point estimate (90% confidence interval) of the test/reference mean ratio for the variable C max is 101% (96.8% to 105%), for AUC(0-∞) 102% (95.3% to 109%), and for C max /AUC(0-∞) 99.0% (91.5% to 107%). The results of this study indicate that the test preparation is bioequivalent to the reference preparation with respect to both the rate and extent of formation of desmethylselegiline and methamphetamine.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI